Josef Coresh

Nephrology · 2000–2021

A researcher in the Science corpus: 60 papers; trusts 7 researchers and is trusted by 18 researchers here, as inferred from the citation graph.

Subfields

Whom Josef Coresh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Levey
  2. B. Astor
  3. Tom Greene
  4. L. Stevens
  5. Kai-Uwe Eckardt
  6. K. Matsushita
  7. G. Eknoyan

Who trusts Josef Coresh overall

  1. A. Levey
  2. Qiu-li Zhang
  3. L. Stevens
  4. B. Astor
  5. D. Rothenbacher
  6. Tom Greene
  7. M. Melamed
  8. R. Verbeeck
  9. Christopher H. Schmid
  10. Tatiana Y. Besschetnova

Papers from Josef Coresh's perspective

Ordered by how strongly the researchers Josef Coresh trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
  2. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  3. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
  4. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
  5. A simplified equation to predict glomerular filtration rate from serum creatinine
  6. Age affects outcomes in chronic kidney disease. (Journal of the American Society of Nephrology)
  7. Assessing kidney function--measured and estimated glomerular filtration rate. (New England Journal of Medicine)
  8. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. (American Journal of Kidney Diseases)
  9. Conference
  10. The support of human genetic evidence for approved drug indications (Nature Genetics)

Their papers